Abstract
Introduction
Though Wilms tumor (WT) is one of the most common malignancies in children, there is a paucity of epidemiologic studies exploring sociodemographic disparities in treatment and survival. Here, we leveraged a national cancer registry to examine sociodemographic factors associated with receipt of adjuvant therapy, either chemotherapy or radiation, as well as overall survival among pediatric patients with WT.
Materials and methods
Within the Surveillance Epidemiology and End Results database (2000–2016), we identified 2043 patients (≤ 20 years of age) with unilateral WT. Multivariable logistic regression and Cox proportional hazard models were constructed to examine the association of sociodemographic factors with, respectively, adjuvant chemotherapy/radiotherapy and overall survival (OS).
Results
Patients in the lowest SES quintile (OR 0.56, 95% CI 0.33–0.93, p = 0.03) were less likely to receive chemotherapy as compared to those in the highest SES quintile, though this association did not persist in sensitivity analyses including only patients at least 2 years of age and patients with regional/distant disease. In addition, female patients were more likely to receive chemotherapy (OR 1.46, 95% CI 1.08–1.97, p = 0.02) than male patients. Age, race, year of diagnosis, insurance status, and tumor laterality were not associated with receipt of chemotherapy. No sociodemographic variables were associated with receipt of radiotherapy. Lastly, as compared to Non-Hispanic-White patients, Hispanic patients had worse OS (HR 1.59, 95% CI 1.08–2.35, p = 0.02); no other sociodemographic variables were associated with OS.
Conclusions
This study suggests multilevel sociodemographic disparities involving ethnicity and SES in WT treatment and survival.
Similar content being viewed by others
Availability of data and materials
Publicly available dataset.
Code availability
Available on reasonable request to the authors.
References
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Breslow N, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21(3):172–181
Dumoucel S, Gauthier-Villars M, Stoppa-Lyonnet D et al (2014) Malformations, genetic abnormalities, and Wilms tumor. Pediatr Blood Cancer 61(1):140–144
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Available at: http://seer.cancer.gov/csr/1975_2012/results_merged/sect_29_childhood_cancer_iccc.pdf
Dome JS, Graf N, Geller JI et al (2015) Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol 33(27):2999–3007
Balis F, Green DM, Anderson C et al (2021) Wilms tumor (Nephroblastoma), Version 2. 2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(8):945–977
Grovas A, Fremgen A, Rauck A et al (1997) The national cancer data base report on patterns of childhood cancers in the united states. Cancer 80(12):2321–2332
Goodman MT, Yoshizawa CN, Kolonel LN (1989) Ethnic patterns of childhood cancer in Hawaii between 1960 and 1984. Cancer 64(8):1758–1763
Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52(4):682–703
Cunningham ME, Klug TD, Nuchtern JG et al (2020) Global disparities in Wilms tumor. J Surg Res 247:34–51
Surveillance Epidemiology and End Results Program (www.seer.cancer.gov). Database: Census Tract-level SES and Rurality Database (2000–2015).
Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711
Parker RA, Weir CJ (2020) Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification. Clin Trials 17(5):562–566. https://doi.org/10.1177/1740774520941419
Bhambhvani HP, Greenberg DR, Kasman AM et al (2021) Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: a population-based study. Urol Oncol 39(3):197.e1-197.e8
Washington SL, Neuhaus J, Meng MV, Porten SP (2019) Social determinants of appropriate treatment for muscle-invasive bladder cancer. Cancer Epidemiol Biomarkers Prev 28(8):1339–1344
Jackson CS, Oman M, Patel AM, Vega KJ (2016) Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol 7(Suppl 1):S32-43
Rodrigues A, Li G, Bhambhvani H, Hayden-Gephart M (2021) Socioeconomic disparities in brain metastasis survival and treatment: a population-based study. World Neurosurg 2:2
Bhambhvani HP, Rodrigues AJ, Medress ZA, Hayden GM (2020) Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study. J Neurooncol 147(2):495–501
Chertack N, Ghandour RA, Singla N et al (2020) Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital. Cancer 126(19):4362–4370
Malik AT, Alexander J, Khan SN, Scharschmidt TJ (2021) Has the affordable care act been associated with increased insurance coverage and early-stage diagnoses of bone and soft-tissue sarcomas in adults? Clin Orthop Relat Res 479(3):493–502
Hoehn RS, Rieser CJ, Phelos H et al (2021) Association between Medicaid expansion and diagnosis and management of colon cancer. J Am Coll Surg 232(2):146-156.e1
Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U (2010) Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med 25(11):1172–1177
Milam JE, Meeske K, Slaughter RI et al (2015) Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: the project forward study. Cancer 121(4):605–613. https://doi.org/10.1002/cncr.29105
Yu M, Tatalovich Z, Gibson JT, Cronin KA (2014) Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control 25(1):81–92
Daley S, Kajendrakumar B, Nandhakumar S et al (2021) County-level socioeconomic status adjustment of acute myocardial infarction mortality hospital performance measure in the u. S Healthcare (Basel) 9(11):1424
Volpi C, Shehadeh F, Mylonakis E (2020) The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study. Medicine (Baltimore) 99(9):e19271
Boscoe FP, Liu B, Lee F (2021) A comparison of two neighborhood-level socioeconomic indexes in the United States. Spat Spatiotemporal Epidemiol 37:100412
Funding
This work received no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhambhvani, H.P., Peterson, D.J. & Sheth, K.R. Sociodemographic factors associated with Wilms tumor treatment and survival: a population-based study. Int Urol Nephrol 54, 3055–3062 (2022). https://doi.org/10.1007/s11255-022-03343-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03343-w